drugset / Trial / NCT02420665
Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia
Phase 0
Completed
50 enrolled
M.D. Anderson Cancer Center
National Cancer Institute (NCI) · collabNational Institutes of Health (NIH) · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The goal of this clinical research study is to compare a type of imaging called high-resolution microendoscopy (HRME) for detecting abnormal tissue in the cervix to the standard of care, which is visual inspection with acetic acid (VIA) with a colposcopy procedure. Researchers also want to learn if HRME images can show the difference between cancerous tissue and normal cervical tissue.
Timeline
- Start
- 2015-09-23
- Primary completion
- 2021-05-14
- Completion
- 2021-05-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Proflavine | Diagnostic / imaging agent | 0.01 % | Topical |
| Background | Acetic Acid | Diagnostic / imaging agent | 3 % | Other |
| Background | Acetic Acid | Diagnostic / imaging agent | 5 % | Other |